These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 27600582

  • 1. Updates in hyperkalemia: Outcomes and therapeutic strategies.
    Kovesdy CP.
    Rev Endocr Metab Disord; 2017 Mar; 18(1):41-47. PubMed ID: 27600582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA.
    Cardiovasc Ther; 2012 Jun; 30(3):e156-66. PubMed ID: 21883995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.
    Buysse JM, Huang IZ, Pitt B.
    Future Cardiol; 2012 Jan; 8(1):17-28. PubMed ID: 22185443
    [Abstract] [Full Text] [Related]

  • 8. New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.
    Zannad F, Rossignol P, Stough WG, Epstein M, Alonso Garcia Mde L, Bakris GL, Butler J, Kosiborod M, Berman L, Mebazaa A, Rasmussen HS, Ruilope LM, Stockbridge N, Thompson A, Wittes J, Pitt B.
    Int J Cardiol; 2016 Aug 01; 216():46-51. PubMed ID: 27140336
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Updates on medical management of hyperkalemia.
    Lopes MB, Rocha PN, Pecoits-Filho R.
    Curr Opin Nephrol Hypertens; 2019 Sep 01; 28(5):417-423. PubMed ID: 31268919
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G, Mateş A, Gluhovschi C, Golea O, Gădălean F, Somai M, Ene I, Petrica L, Velciov S.
    Rom J Intern Med; 2014 Sep 01; 52(1):30-8. PubMed ID: 25000676
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperkalemia treatment standard.
    Palmer BF, Clegg DJ.
    Nephrol Dial Transplant; 2024 Jun 28; 39(7):1097-1104. PubMed ID: 38425037
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New drugs for the treatment of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors -- hype or hope?
    Tamargo J, Caballero R, Delpón E.
    Discov Med; 2014 Nov 28; 18(100):249-54. PubMed ID: 25425465
    [Abstract] [Full Text] [Related]

  • 19. New options for the management of chronic hyperkalemia.
    Fried L, Kovesdy CP, Palmer BF.
    Kidney Int Suppl (2011); 2017 Dec 28; 7(3):164-170. PubMed ID: 30675431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.